|
1
|
Jolivet J, Cowan KH, Curt GA, Clendeninn
NJ and Chabner BA: The pharmacology and clinical use of
methotrexate. N Engl J Med. 309:1094–1104. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Samarasekera E, Sawyer L, Parnham J and
Smith CH: Guideline Development Group: Assessment and management of
psoriasis: Summary of NICE guidance. BMJ. 345:e67122012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuroda T, Namba K, Torimaru T, Kawashima K
and Hayashi M: Species differences in oral bioavailability of
methotrexate between rats and monkeys. Biol Pharm Bull. 23:334–338.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carneiro-Filho BA, Lima IP, Araujo DH,
Cavalcante MC, Carvalho GH, Brito GA, Lima V, Monteiro SM, Santos
FN, Ribeiro RA and Lima AA: Intestinal barrier function and
secretion in methotrexate-induced rat intestinal mucositis. Dig Dis
Sci. 49:65–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duman DG, Kumral ZN, Ercan F, Deniz M, Can
G and Cağlayan Yeğen B: Saccharomyces boulardii ameliorates
clarithromycin- and methotrexate-induced intestinal and hepatic
injury in rats. Br J Nutr. 110:493–499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alarcón GS, Tracy IC and Blackburn WD Jr:
Methotrexate in rheumatoid arthritis. Toxic effects as the major
factor in limiting long-term treatment. Arthritis Rheum.
32:671–676. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Li Q, Ivanochko G and Huang Y:
Anticancer effect of extracts from a North American medicinal
plant-wild sarsaparilla. Anticancer Res. 26:2157–2164.
2006.PubMed/NCBI
|
|
8
|
Galhena PB, Samarakoon SR, Thabrew MI,
Weerasinghe GA, Thammitiyagodage MG, Ratnasooriya WD and Tennekoon
KH: Anti-inflammatory activity is a possible mechanism by which the
polyherbal formulation comprised of Nigella sativa (seeds),
Hemidesmus indicus (root), and Smilax glabra (rhizome) mediates its
antihepatocarcinogenic effects. Evid Based Complement Alternat Med.
2012:1086262012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao Y, Su Y, Qu L, Xu S, Meng L, Cai SQ
and Shou C: Mitochondrial apoptosis contributes to the anti-cancer
effect of Smilax glabra Roxb. Toxicol Lett. 207:112–120. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ooi LS, Sun SS, Wang H and Ooi VE: New
mannose-binding lectin isolated from the rhizome of sarsaparilla
Smilax glabra Roxb. (Liliaceae). J Agric Food Chem. 52:6091–6095.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu CL, Zhu W, Wang M, Xu XJ and Lu CJ:
Antioxidant and anti-inflammatory activities of phenolic-enriched
extracts of Smilax glabra. Evid Based Complement Alternat Med.
2014:9104382014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang J and Xu Q: Immunomodulatory
activity of the aqueous extract from rhizome of Smilax glabra in
the later phase of adjuvant-induced arthritis in rats. J
Ethnopharmacol. 85:53–59. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia D, Fan Y, Zhang P, Fu Y, Ju M and
Zhang X: Protective effects of the flavonoid-rich fraction from
rhizomes of Smilax glabra Roxb. On carbon tetrachloride-induced
hepatotoxicity in rats. J Membr Biol. 246:479–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roubille C, Richer V, Starnino T, McCourt
C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, et al:
The effects of tumour necrosis factor inhibitors, methotrexate,
non-steroidal anti-inflammatory drugs and corticosteroids on
cardiovascular events in rheumatoid arthritis, psoriasis and
psoriatic arthritis: A systematic review and meta-analysis. Ann
Rheum Dis. 74:480–489. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen L, Yin Y, Yi H, Xu Q and Chen T:
Simultaneous quantification of five major bioactive flavonoids in
Rhizoma Smilacis Glabrae by high-performance liquid chromatography.
J Pharm Biomed Anal. 43:1715–1720. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi L, Xu L, Yang Y, Song H, Pan H and Yin
L: Suppressive effect of modified Simiaowan on experimental gouty
arthritis: An in vivo and in vitro study. J Ethnopharmacol.
150:1038–1044. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Smith CH and Barker JN: Psoriasis and its
management. BMJ. 333:380–384. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y: Clinical observation of combining
traditional Chinese and western medicine treatment rheumatoid
arthritis. J New Chin Med. 47:103–105. 2015.
|
|
19
|
Goldman ID and Matherly LH: The cellular
pharmacology of methotrexate. Pharmacol Ther. 28:77–102. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Henderson GB: Folate-binding proteins.
Annu Rev Nutr. 10:319–335. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Graaf D, Sharma RC, Mechetner EB,
Schimke RT and Roninson IB: P-glycoprotein confers methotrexate
resistance in 3T6 cells with deficient carrier-mediated
methotrexate uptake. Proc Natl Acad Sci USA. 93:1238–1242. 1996;
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Masuda M, I'Izuka Y, Yamazaki M, Nishigaki
R, Kato Y, Ni'inuma K, Suzuki H and Sugiyama Y: Methotrexate is
excreted into the bile by canalicular multispecific organic anion
transporter in rats. Cancer Res. 57:3506–3510. 1997.PubMed/NCBI
|
|
23
|
Kusuhara H and Sugiyama Y: Role of
transporters in the tissue-selective distribution and elimination
of drugs: Transporters in the liver, small intestine, brain and
kidney. J Control Release. 78:43–54. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ranganathan P and McLeod HL: Methotrexate
pharmacogenetics: The first step toward individualized therapy in
rheumatoid arthritis. Arthritis Rheum. 54:1366–1377. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
El-Sheikh AA, van den Heuvel JJ,
Koenderink JB and Russel FG: Interaction of nonsteroidal
anti-inflammatory drugs with multidrug resistance protein (MRP)
2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. J
Pharmacol Exp Ther. 320:229–235. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sweet DH, Bush KT and Nigam SK: The
organic anion transporter family: From physiology to ontogeny and
the clinic. Am J Physiol Renal Physiol. 281:F197–F205.
2001.PubMed/NCBI
|
|
27
|
Sweet DH: Organic anion transporter
(Slc22a) family members as mediators of toxicity. Toxicol Appl
Pharmacol. 204:198–215. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang XD, Meng MX, Gao LB, Liu T, Xu Q and
Zeng S: Permeation of astilbin and taxifolin in Caco-2 cell and
their effects on the P-gp. Int J Pharm. 378:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Piskula MK: Factors affecting flavonoids
absorption. Biofactors. 12:175–180. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
O'Leary KA, Day AJ, Needs PW, Mellon FA,
O'Brien NM and Williamson G: Metabolism of quercetin-7- and
quercetin-3-glucuronides by an in vitro hepatic model: The role of
human beta-glucuronidase, sulfotransferase,
catechol-O-methyltransferase and multi-resistant protein 2 (MRP2)
in flavonoid metabolism. Biochem Pharmacol. 65:479–491. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Van Aubel RA, Masereeuw R and Russel FG:
Molecular pharmacology of renal organic anion transporters. Am J
Physiol Renal Physiol. 279:F216–F232. 2000.PubMed/NCBI
|
|
32
|
Hirohashi T, Suzuki H and Sugiyama Y:
Characterization of the transport properties of cloned rat
multidrug resistance-associated protein 3 (MRP3). J Biol Chem.
274:15181–15185. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang M, Chen W, Wang Z, Lu C and Zhu W:
HP-20 macroporous adsorption resin enrichment and purification of
total flavonoids of glabrous greenbrier rhizome. Chin Tradit Patent
Med. 37:2074–2078. 2015.(In Chinese).
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jacobs SA, Stoller RG, Chabner BA and
Johns DG: 7-Hydroxymethotrexate as a urinary metabolite in human
subjects and rhesus monkeys receiving high dose methotrexate. J
Clin Invest. 57:534–538. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kuijpers AL and van de Kerkhof PC:
Risk-benefit assessment of methotrexate in the treatment of severe
psoriasis. Am J Clin Dermatol. 1:27–39. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oliverio VT and Zaharko DS: Tissue
distribution of folate antagonists. Ann N Y Acad Sci. 186:387–399.
1971. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Scheufler E, Zetler G and Iven H:
Pharmacokinetics and organ distribution of methotrexate in the rat.
Pharmacology. 23:75–81. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chinese Pharmacopoeia Commission:
Pharmacopoeia of the People's Republic of China 2015. China Medical
Science and Technology Press; Bejing: 2015, (In Chinese).
|
|
40
|
Chinese Pharmacopoeia Commission:
Pharmacopoeia of the People's Republic of China, the First
Division. China Medical Science and Technology Press; Bejing: 2010,
(In Chinese).
|
|
41
|
Aquerreta I, Aldaz A, Giráldez J and
Sierrasesúmaga L: Methotrexate pharmacokinetics and survival in
osteosarcoma. Pediatr Blood Cancer. 42:52–58. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chiang HM, Fang SH, Wen KC, Hsiu SL, Tsai
SY, Hou YC, Chi YC and Chao PD: Life-threatening interaction
between the root extract of Pueraria lobata and methotrexate in
rats. Toxicol Appl Pharmacol. 209:263–268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao R, Liu L, Wang Y and Xiao Z:
Vinegar-baked Radix Bupleuri modulates the cell membrane
constituents and inhibits the P-gp activity in rat hepatocytes. BMC
Complement Altern Med. 14:3572014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao Y, Feng LM, Liu LJ, Zhang X and Zhao
RZ: Clerosterol from vinegar-baked radix bupleuri modifies drug
transport. Oncotarget. 8:21351–21361. 2017.PubMed/NCBI
|
|
45
|
Takatori R, Takahashi KA, Tokunaga D, Hojo
T, Fujioka M, Asano T, Hirata T, Kawahito Y, Satomi Y, Nishino H,
et al: ABCB1 C3435T polymorphism influences methotrexate
sensitivity in rheumatoid arthritis patients. Clin Exp Rheumatol.
24:546–554. 2006.PubMed/NCBI
|
|
46
|
Grabar P Bohanec, Logar D, Lestan B and
Dolzan V: Genetic determinants of methotrexate toxicity in
rheumatoid arthritis patients: A study of polymorphisms affecting
methotrexate transport and folate metabolism. Eur J Clin Pharmacol.
64:1057–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Boušová I and Skálová L: Inhibition and
induction of glutathione S-transferases by flavonoids: Possible
pharmacological and toxicological consequences. Drug Metab Rev.
44:267–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lin SP, Tsai SY, Hou YC and Chao PD:
Glycyrrhizin and licorice significantly affect the pharmacokinetics
of methotrexate in rats. J Agric Food Chem. 57:1854–1859. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang SY, Juang SH, Tsai SY, Chao PD and
Hou YC: St. John's wort significantly increased the systemic
exposure and toxicity of methotrexate in rats. Toxicol Appl
Pharmacol. 263:39–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hirota BC, Paula CD, de Oliveira VB, da
Cunha JM, Schreiber AK, Ocampos FM, Barison A, Miguel OG and Miguel
MD: Phytochemical and antinociceptive, anti-inflammatory, and
antioxidant studies of Smilax larvata (Smilacaceae). Evid Based
Complement Alternat Med. 2016:98946102016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
She T, Zhao C, Feng J, Wang L, Qu L, Fang
K, Cai S and Shou C: Sarsaparilla (Smilax glabra Rhizome) extract
inhibits migration and invasion of cancer cells by suppressing
TGF-β1 pathway. PLoS One. 10:e01182872015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
She T, Qu L, Wang L, Yang X, Xu S, Feng J,
Gao Y, Zhao C, Han Y, Cai S and Shou C: Sarsaparilla (Smilax glabra
Rhizome) extract inhibits cancer cell growth by S phase arrest,
apoptosis, and autophagy via redox-dependent ERK1/2 pathway. Cancer
Prev Res (Phila). 8:464–474. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Samarakoon SR, Thabrew I, Galhena PB and
Tennekoon KH: Modulation of apoptosis in human hepatocellular
carcinoma (HepG2 cells) by a standardized herbal decoction of
Nigella sativa seeds, Hemidesmus indicus roots and Smilax glabra
rhizomes with anti-hepatocarcinogenic effects. BMC Complement
Altern Med. 12:252012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ooi LS, Wong EY, Chiu LC, Sun SS and Ooi
VE: Antiviral and anti-proliferative glycoproteins from the rhizome
of Smilax glabra Roxb (Liliaceae). Am J Chin Med. 36:185–195. 2008.
View Article : Google Scholar : PubMed/NCBI
|
